文献速递糖尿病肥胖与代谢综合征

血糖生成指数与血糖负荷与2型糖尿病、心血管疾病、癌症及全因死亡率的关联:对超过10万名参与者的超大队列的荟萃分析

Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality: a meta-analysis of mega cohorts of more than 100 000 participants.
PubMed 文献 · Lancet Diabetes Endocrinol · 2024-01-01

该荟萃分析纳入10个大型前瞻性队列(≥10万参与者)的48项研究,评估血糖生成指数(GI)和血糖负荷(GL)与2型糖尿病、心血管疾病、糖尿病相关癌症及全因死亡率的关联。高GI食物摄入与2型糖尿病(RR 1.27,95%CI 1.21-1.34)、总心血管疾病(RR 1.15,95%CI 1.11-1.19)、糖尿病相关癌症(RR 1.05,95%CI 1.02-1.08)及全因死亡率(RR 1.08,95%CI 1.05-1.12)风险增加相关。高GL与糖尿病(RR 1.15,95%CI 1.09-1.21)和总心血管疾病(RR 1.15,95%CI 1.10-1.20)呈相似关联。

要点

  • 高GI食物摄入与2型糖尿病风险增加相关(RR 1.27,95%CI 1.21-1.34)。
  • 高GI食物摄入与总心血管疾病风险增加相关(RR 1.15,95%CI 1.11-1.19)。
  • 高GL与2型糖尿病和总心血管疾病风险增加相关(RR均为1.15)。

核心结论

  • 减少GI和GL的饮食建议对健康结局的影响可能与增加纤维和全谷物摄入的建议相似。

研究设计与样本

  • 从Richard Doll Consortium中识别大型队列(≥10万参与者)进行荟萃分析,检索Cochrane Library、MEDLINE、PubMed、Embase、Web of Science和Scopus从数据库建立至2023年8月4日的前瞻性队列研究。
  • 纳入10个前瞻性大型队列(6个来自美国,1个来自欧洲,2个来自亚洲,1个国际队列),共48项研究报告GI或GL与结局的关联:34项(71%)关于各种癌症,9项(19%)关于心血管疾病,5项(10%)关于2型糖尿病,3项(6%)关于全因死亡率。

主要发现

  • 高GI食物摄入与2型糖尿病发病率增加相关(RR 1.27,95%CI 1.21-1.34;p<0.0001)。
  • 高GI食物摄入与总心血管疾病(包括死亡)风险增加相关(RR 1.15,95%CI 1.11-1.19;p<0.0001)。
  • 高GI食物摄入与糖尿病相关癌症风险增加相关(RR 1.05,95%CI 1.02-1.08;p=0.0010)。
  • 高GI食物摄入与全因死亡率风险增加相关(RR 1.08,95%CI 1.05-1.12;p<0.0001)。
  • 高GL与糖尿病(RR 1.15,95%CI 1.09-1.21;p<0.0001)和总心血管疾病(RR 1.15,95%CI 1.10-1.20;p<0.0001)呈相似关联。

关键数值与推荐

  • 比较GI和GL最低与最高分位数,调整膳食因素,采用固定效应模型合并最调整的相对危险度(RR)估计值。
  • 高纤维和全谷物饮食与四个主要结局的关联与低GI饮食相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is debate over whether the glycaemic index of foods relates to chronic disease. We aimed to assess the associations between glycaemic index (GI) and glycaemic load (GL) and type 2 diabetes, cardiovascular disease, diabetes-related cancers, and all-cause mortality. METHODS: We did a meta-analysis of large cohorts (≥100 000 participants) identified from the Richard Doll Consortium. We searched the Cochrane Library, MEDLINE, PubMed, Embase, Web of Science, and Scopus for cohorts that prospectively examined associations between GI or GL and chronic disease outcomes published from database inception to Aug 4, 2023. Full-article review and extraction of summary estimates data were conducted by three independent reviewers. Primary outcomes were incident type 2 diabetes, total cardiovascular disease (including mortality), diabetes-related cancers (ie, bladder, breast, colorectal, endometrial, hepatic, pancreatic, and non-Hodgkin lymphoma), and all-cause mortality. We assessed comparisons between the lowest and highest quantiles of GI and GL, adjusting for dietary factors, and pooling their most adjusted relative risk (RR) estimates using a fixed-effects model. We also assessed associations between diets high in fibre and whole grains and the four main outcomes. The study protocol is registered with PROSPERO, CRD42023394689. FINDINGS: From ten prospective large cohorts (six from the USA, one from Europe, two from Asia, and one international), we identified a total of 48 studies reporting associations between GI or GL and the outcomes of interest: 34 (71%) on various cancers, nine (19%) on cardiovascular disease, five (10%) on type 2 diabetes, and three (6%) on all-cause mortality. Consumption of high GI foods was associated with an increased incidence of type 2 diabetes (RR 1·27 [95% CI 1·21-1·34]; p<0·0001), total cardiovascular disease (1·15 [1·11-1·19]; p<0·0001), diabetes-related cancer (1·05 [1·02-1·08]; p=0·0010), and all-cause mortality (1·08 [1·05-1·12]; p<0·0001). Similar associations were seen between high GL and diabetes (RR 1·15 [95% CI 1·09-1·21]; p<0·0001) and total cardiovascular disease (1·15 [1·10-1·20]; p<0·0001). Associations between diets high in fibre and whole grains and the four main outcomes were similar to those for low GI diets. INTERPRETATION: Dietary recommendations to reduce GI and GL could have effects on health outcomes that are similar to outcomes of recommendations to increase intake of fibre and whole grain. FUNDING: Banting and Best and the Karuna Foundation.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Jenkins DJA, Willett WC, Yusuf S, et al. Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality: a meta-analysis of mega cohorts of more than 100 000 participants. Lancet Diabetes Endocrinol. 2024. PMID: 38272606. doi:10.1016/S2213-8587(23)00344-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。